MRGPRX2 and urticaria: Mast cell MRGPRX2 plays a pivotal role in mediating pseudo-allergic reactions to several FDA approved drugs (3, 19–24) and chronic inflammation associated with asthma (18), urticaria (7), and rosacea (6).